News Coverage

March 23, 2017
It’s on: Cornerstone gets green light for two pivotal cancer trials

February 14, 2017
Interview of Sanjeev Luther (COO, Cornerstone Pharmaceuticals) on WCTC-Radio

January 16, 2017
JP Morgan Biotech (The Price of Business): Sanjeev Luther and Tim Pardee on CPI-613

December 5, 2016
ecancer: Dr Timothy Pardee at ASH 2016 on TCA cycle inhibition by CPI-613 in older AML patients

December 5, 2016
ecancer: Dr Zanetta Lamar at ASH 2016 on dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL

January 2015
OncLive: Dr. Powell at ASH 2014 on CPI-613, Cytarabine, Mitoxantrone Combo for AML

December 2014
December 2013 OncLive: Dr. Pardee Provides an Update on CPI-613 in advanced hematologic malignancies

November 2013
About.com Biotech / Biomedical: Seven Areas of Focus for Research on New Cancer Therapies

November 2013
BioWorld Today: Clinic Roundup (subscription required)

November 2013
Drug Development Technology: Cornerstone begins Phase II study of pancreatic cancer drug

November 2013
Pharmaceutical Business Review: Cornerstone initiates Phase II trial of CPI-613 to treat metastatic pancreatic cancer patients

October 2013
Drug Development Technology: Cornerstone begins Phase II trial of lung cancer drug

October 2013
BioPharma International: Cornerstone Pharmaceuticals Receives FDA Orphan Drug Designation

October 2013
Medical News Today: Cornerstone Pharmaceuticals receives FDA orphan drug designation of CPI-613 for treatment of myelodysplastic syndrome

October 2013
NJBiz: Cornerstone granted orphan drug designation

October 2013
LymphomaInfo.net: Cornerstone Gets Orphan Drug Status For MDS Treatment

October 2013
Hematology Times: Drug gets orphan designation for MDS

October 2013
The MDS Beacon: Cornerstone Pharmaceuticals Receives FDA Orphan Drug Designation Of CPI-613 For Treatment Of Myelodysplastic Syndrome

October 2013
Oncology Times: FDA Grants MDS Drug CPI-613 Orphan Drug Status

July 2013
OncLive: Dr. Pardee on CPI-613 in Hematologic Malignancies

June 2013
OncLive: Dr. Powell Discusses CPI-613 in Hematologic Malignancies

December 2011
Drug Discovery & Development: Cornerstone Releasing CPI-613 Data

December 2011
BioWorld Today: ASH Roundup (subscription required)

December 2011
Drug Discovery & Development: On Target Delivery

September 2011
BioCentury: Powering down cancer

August 2011
BioWorld Today: Bench Press (subscription required)

December 2010
The New York Times: Fuel lines of tumors are new target

September 2010
Cornerstone featured in Start-Up Magazine profile

August 2010
Drug Discovery News special report: Trends in cancer research

May 2010
Drug Discovery News: Cancer research turns a corner